dopamine D1 receptor

Trials

10 participants · First posted Jul 28, 2004

Completed

NCT00094601

Relationship of Dopamine to Cognitive Function in Parkinson's Disease

75 participants · First posted Oct 21, 2004

Completed

NCT01065558

Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease

5 participants · First posted Feb 9, 2010

Drugs

View all 1438 →

Small Molecule

Approved

Fenoldopam(Corlopam)

Manufacturer: Hospira inc, Bedford laboratories +3 more

Conditions: Malignant Hypertension, Severe Hypertension

C₁₆H₁₆ClNO₃

Targeting D1 dopamine small molecule (ConfometRx)

Small Molecule

Approved

Dopamine(Neoatricon)

Manufacturer: Abbott laboratories hosp products div, Abraxis pharmaceutical products +10 more

Conditions: Arrhythmia, Circulatory collapse and shock +3 more

C₈H₁₁NO₂ · Rx

Organizations

View all 30 →

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Veru Inc

United States

News

View all 5186 →

last year

UCB's Minzasolmin Fails Phase 2 ORCHESTRA Trial for Early Parkinson's Disease

last year

IQVIA Gains CDSCO Panel Approval for Phase III Lumateperone Trial in Pediatric Bipolar Depression

last year

Trials

Positron Emission Tomography Imaging of Dopamine Receptors Using the Tracer [11C]NNC-112

Relationship of Dopamine to Cognitive Function in Parkinson's Disease

Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease

Drugs

Fenoldopam(Corlopam)

Targeting D1 dopamine small molecule (ConfometRx)

Dopamine(Neoatricon)

Organizations

Arvinas Estrogen Receptor, Inc.

Arvinas Androgen Receptor, Inc.

Veru Inc

News

UCB's Minzasolmin Fails Phase 2 ORCHESTRA Trial for Early Parkinson's Disease

IQVIA Gains CDSCO Panel Approval for Phase III Lumateperone Trial in Pediatric Bipolar Depression

UCB Showcases Promising Neurodegenerative Disease Research at AD/PD 2025